Literature DB >> 28338401

Challenges associated and approaches for successful translation of nanomedicines into commercial products.

Vivek Agrahari1, Praveen Hiremath2.   

Abstract

Keywords:  characterization; clinical challenges; commercialization; manufacturing scale-up; nanomedicine; nanopharmaceuticals; regulatory challenges; reproducibility

Mesh：

Substances：

Year:  2017        PMID： 28338401     DOI： 10.2217/nnm-2017-0039

Source DB:  PubMed          Journal:  Nanomedicine (Lond)        ISSN： 1743-5889            Impact factor:   5.307


× No keyword cloud information.
  14 in total

1.  Novel drug delivery systems, devices, and fabrication methods.

Authors:  Vivek Agrahari
Journal:  Drug Deliv Transl Res       Date:  2018-04       Impact factor: 4.617

2.  Counterion of Chitosan Influences Thermodynamics of Association of siRNA with a Chitosan-Based siRNA Carrier.

Authors:  Christelle Zandanel; Magali Noiray; Christine Vauthier
Journal:  Pharm Res       Date:  2020-01-02       Impact factor: 4.200

Review 3.  Exploration of novel drug delivery systems in topical management of osteoarthritis.

Authors:  Pratiksha Patil; Shweta Nene; Saurabh Shah; Shashi Bala Singh; Saurabh Srivastava
Journal:  Drug Deliv Transl Res       Date:  2022-08-28       Impact factor: 5.671

Review 4.  Nanocarriers for ocular drug delivery: current status and translational opportunity.

Authors:  Srividya Gorantla; Vamshi Krishna Rapalli; Tejashree Waghule; Prem Prakash Singh; Sunil Kumar Dubey; Ranendra N Saha; Gautam Singhvi
Journal:  RSC Adv       Date:  2020-07-24       Impact factor: 4.036

Review 5.  Nanomedicine: Principles, Properties, and Regulatory Issues.

Authors:  Sara Soares; João Sousa; Alberto Pais; Carla Vitorino
Journal:  Front Chem       Date:  2018-08-20       Impact factor: 5.221

Review 6.  Extracellular Vesicles As Nanomedicine: Hopes And Hurdles In Clinical Translation.

Authors:  Thierry Burnouf; Vibhuti Agrahari; Vivek Agrahari
Journal:  Int J Nanomedicine       Date:  2019-11-12

7.  The Impact of Polymer Size and Cleavability on the Intravenous Pharmacokinetics of PEG-Based Hyperbranched Polymers in Rats.

Authors:  Nirmal Marasini; Changkui Fu; Nicholas L Fletcher; Christopher Subasic; Gerald Er; Karine Mardon; Kristofer J Thurecht; Andrew K Whittaker; Lisa M Kaminskas
Journal:  Nanomaterials (Basel)       Date:  2020-12-08       Impact factor: 5.076

8.  Dexamethasone-Loaded Nanostructured Lipid Carriers for the Treatment of Dry Eye Disease.

Authors:  Sangeeta Kumari; Madhuri Dandamudi; Sweta Rani; Elke Behaeghel; Gautam Behl; David Kent; Niall J O'Reilly; Orla O'Donovan; Peter McLoughlin; Laurence Fitzhenry
Journal:  Pharmaceutics       Date:  2021-06-18       Impact factor: 6.321

Review 9.  An Elucidative Review to Analytically Sieve the Viability of Nanomedicine Market.

Authors:  Anaida Kad; Archit Pundir; Shailendra Kumar Arya; Neha Bhardwaj; Madhu Khatri
Journal:  J Pharm Innov       Date:  2020-09-21       Impact factor: 2.538

Review 10.  Current hurdles to the translation of nanomedicines from bench to the clinic.

Authors:  Snežana Đorđević; María Medel Gonzalez; Inmaculada Conejos-Sánchez; Barbara Carreira; Sabina Pozzi; Rita C Acúrcio; Ronit Satchi-Fainaro; Helena F Florindo; María J Vicent
Journal:  Drug Deliv Transl Res       Date:  2021-07-23       Impact factor: 4.617
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.